As of 2026-03-27, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (25.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -3753.9%.
The range of the Relative Valuation is (23.64) - (27.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 22.8x | 20.0x |
| Forward P/E multiples | 17.8x - 21.5x | 20.4x |
| Fair Price | (23.64) - (27.18) | (25.56) |
| Upside | -3478.9% - -3985.4% | -3753.9% |
| Date | P/E |